Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
Molecular Cancer Therapeutics
|
February 20, 2007
Combining radiotherapy with AZD2171, a potent inhibitor of vascular endothelial growth factor signaling: pathophysiologic effects and therapeutic benefit
Kaye J Williams, Brian A Telfer, Aoife M Shannon, et al.
Scientific Reports
|
October 29, 2015
Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells
Emily G Armitage, Helen L Kotze, J William Allwood, et al.
Nature Reviews. Immunology
|
July 2, 2021
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Urszula M Cytlak, Douglas P Dyer, Jamie Honeychurch, et al.
Chemical Communications (Cambridge, England)
|
December 3, 2014
Binary behaviour of an oxidation-responsive MRI nano contrast agent
Damien Jeanmaire, Grigore A Timco, Arianna Gennari, et al.
Plos One
|
February 6, 2016
Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo
Suzanne L Meredith, Jennifer L Bryant, Muhammad Babur, et al.
Radiation Oncology (London, England)
|
August 2, 2019
Preclinical dosimetry: exploring the use of small animal phantoms
Emma R Biglin, Gareth J Price, Amy L Chadwick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity
Kaye J Williams, Brian A Telfer, Sandra Brave, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 14, 2011
GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways
Natalie Burrows, Muhammad Babur, Julia Resch, et al.
Rapid Communications in Mass Spectrometry : RCM
|
February 28, 2018
Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionisation mass spectrometry
Fiona Henderson, Philippa J Hart, Jesus M Pradillo, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase
Paul E Murray, Virginia A McNally, Stacey D Lockyer, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
Molecular Cancer Therapeutics
|
February 20, 2007
Combining radiotherapy with AZD2171, a potent inhibitor of vascular endothelial growth factor signaling: pathophysiologic effects and therapeutic benefit
Kaye J Williams, Brian A Telfer, Aoife M Shannon, et al.
Scientific Reports
|
October 29, 2015
Metabolic profiling reveals potential metabolic markers associated with Hypoxia Inducible Factor-mediated signalling in hypoxic cancer cells
Emily G Armitage, Helen L Kotze, J William Allwood, et al.
Nature Reviews. Immunology
|
July 2, 2021
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
Urszula M Cytlak, Douglas P Dyer, Jamie Honeychurch, et al.
Chemical Communications (Cambridge, England)
|
December 3, 2014
Binary behaviour of an oxidation-responsive MRI nano contrast agent
Damien Jeanmaire, Grigore A Timco, Arianna Gennari, et al.
Plos One
|
February 6, 2016
Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo
Suzanne L Meredith, Jennifer L Bryant, Muhammad Babur, et al.
Radiation Oncology (London, England)
|
August 2, 2019
Preclinical dosimetry: exploring the use of small animal phantoms
Emma R Biglin, Gareth J Price, Amy L Chadwick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2004
ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity
Kaye J Williams, Brian A Telfer, Sandra Brave, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 14, 2011
GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways
Natalie Burrows, Muhammad Babur, Julia Resch, et al.
Rapid Communications in Mass Spectrometry : RCM
|
February 28, 2018
Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionisation mass spectrometry
Fiona Henderson, Philippa J Hart, Jesus M Pradillo, et al.
Bioorganic & Medicinal Chemistry
|
January 30, 2002
Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase
Paul E Murray, Virginia A McNally, Stacey D Lockyer, et al.
Page
of 10